نتایج جستجو برای: das28

تعداد نتایج: 1719  

2013
Yoshiya Tanaka Shintaro Hirata Satoshi Kubo Shunsuke Fukuyo Kentaro Hanami Norifumi Sawamukai Kazuhisa Nakano Shingo Nakayamada Kunihiro Yamaoka Fusae Sawamura Kazuyoshi Saito Tore K Kvien

To cite: Tanaka Y, Hirata S, Kubo S, et al. Ann Rheum Dis Published Online First: [please include Day Month Year] doi:10.1136/ annrheumdis-2013-204016 ABSTRACT Objectives To investigate the possibility of discontinuing adalimumab (ADA) for 1 year without flaring (DAS28erythrocyte sedimentation rate (ESR) ≥3.2), and to identify factors enabling established patients with rheumatoid arthritis (RA)...

2017
Seong Kyu KIM Jung Yoon CHOE Seong Kyu Kim

©2018 Turkish League Against Rheumatism. All rights reserved. ABSTRACT Objectives: This study aims to evaluate the effects of passive smoking on disease activity in female patients with rheumatoid arthritis (RA). Patients and methods: Among a total of 191 female patients with RA (mean age 59.1±12.5 years; range 21 to 87 years) consecutively recruited, 100 female patients (mean age 56.1±13.4 yea...

2013
Michelle J Ormseth Annette M Oeser Andrew Cunningham Aihua Bian Ayumi Shintani Joseph Solus S Bobo Tanner C Michael Stein

INTRODUCTION Rheumatoid arthritis (RA), a chronic inflammatory disease, is associated with insulin resistance. Experimental evidence indicates that the relationship between insulin resistance and inflammation is bidirectional: Inflammation promotes insulin resistance, and insulin resistance promotes inflammation. Therefore, we examined the hypothesis that pioglitazone, a thiazolidinedione perox...

Journal: :Arthritis Research & Therapy 2005
Piet LCM van Riel Jaap Fransen

The Disease Activity Score using 28 joint counts (DAS28) has been developed in a cohort of patients with rheumatoid arthritis in which only conventional anti-rheumatic treatments were used. It has extensively been validated to monitor disease activity in daily clinical practice as well as in clinical trials. The study of Vander Cruyssen and colleagues showed that the DAS28 correlated best with ...

Journal: :Annals of the rheumatic diseases 2010
G M Bartelds C A Wijbrandts M T Nurmohamed S Stapel W F Lems L Aarden B A C Dijkmans P P Tak G J Wolbink

OBJECTIVE To investigate how antibodies against anti-tumour necrosis factor (anti-TNF) agents influence response after switching from infliximab to adalimumab in rheumatoid arthritis (RA). METHODS This cohort study consisted of 235 patients with RA, all treated with adalimumab. At baseline 52 patients (22%) had been previously treated with infliximab ('switchers'), and 183 (78%) were anti-TNF...

ژورنال: :مجله دانشکده پزشکی اصفهان 0
منصور ثالثی استادیار، گروه روماتولوژی، دانشکده ی پزشکی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران هنگامه جمشیدی دستیار، گروه داخلی، دانشکده ی پزشکی و کمیته ی تحقیقات دانشجویی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران زیبا فرج زاد گان دانشیار، گروه پزشکی اجتماعی، دانشکده ی پزشکی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران هادی کریم زاده دانشیار، گروه روماتولوژی، دانشکده ی پزشکی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران

مقدمه: برخی مطالعات اندازه گیری تیتر anti-mcv (anti-mutated citrullinated vimentin antibodies) را به عنوان یک تست اختصاصی برای تشخیص و پیشرفت بیماری آرتریت روماتویید شناخته و سطح آن را با نمره ی فعالیت بیماری ( disease activity score calculator for rheumatoid arthritis یا das28) مرتبط دانسته اند. هدف ما از انجام این مطالعه، بررسی ارتباط تیتر این آنتی بادی با فعالیت بیماری و تغییرات آن طی درمان ...

Journal: :journal of research in medical sciences 0
voja pavlovic aleksandar dimic sasa milenkovic dane krtinic

background: rheumatoid arthritis (ra) is a chronic, systemic, inflammatory disease with autoimmune etiology, characterized by synovial inflammation and destruction of joint cartilage and bone. there are controversial data about the profile of interleukin-17 (il-17a), interleukin-4 (il-4), and interferon-gamma (infî³), indicating in some studies the key role of il-17, while in others the th1 cyt...

2016
Qiong Wu Hema Chaplin Nicola Ambrose Debajit Sen Maria J Leandro Charlotte Wing Nicola Daly Kate Webb Corinne Fisher Linda Suffield Francesca Josephs Clarissa Pilkington Despina Eleftheriou Muthana Al-Obaidi Sandrine Compeyrot-Lacassagne Lucy R Wedderburn Yiannis Ioannou

A considerable proportion of children with polyarticular juven-ile idiopathic arthritis (polyJIA) experience active disease into adulthood. However, there is no validated disease activity measure for adults with polyJIA, and they are often assessed using the disease activity score 28 (DAS28). DAS28 is validated in adults with rheumatoid arthritis (RA), and determines qualification for biologica...

Journal: :Annals of the rheumatic diseases 2003
R van Vollenhoven A Harju S Brannemark L Klareskog

OBJECTIVE When one TNFalpha blocker (etanercept or infliximab) has failed, to determine whether it makes sense to treat patients with the other. PATIENTS AND METHODS Since 1999 patients treated with etanercept or infliximab have been systematically followed up at our institution in the STURE database. We identified 31 patients who had received both agents. RESULTS Eighteen patients received...

2015
Yasuo Iwata

We report three cases of previous smokers who did not respond to TNF inhibitors but who responded successfully to an anti-interleukin-6 receptor antibody (tocilizumab (TCZ)). Case 1 is a 63-year-old woman whose smoking index was 200 and had been complaining of polyarthralgia since 1996. She started treatment with etanercept due to high disease activity, but her DAS28-CRP was 4.2. She was theref...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید